Haemolytic-uraemic syndrome during severe lupus nephritis: efficacy of plasma exchange
Systemic lupus erythematosus (SLE) has been described as a cause of thrombotic microangiopathy, especially thrombotic thrombocytopenic purpura (TTP). Haemolytic‐uraemic syndrome (HUS) is less frequent in SLE. We report a case of such an association during an episode of severe lupus nephritis in a yo...
Gespeichert in:
| Veröffentlicht in: | Internal medicine journal 2012-01, Vol.42 (1), p.95-98 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 98 |
|---|---|
| container_issue | 1 |
| container_start_page | 95 |
| container_title | Internal medicine journal |
| container_volume | 42 |
| creator | Samson, M. Audia, S. Leguy, V. Berthier, S. Janikashvili, N. Martin, L. Bonnotte, B. Lorcerie, B. |
| description | Systemic lupus erythematosus (SLE) has been described as a cause of thrombotic microangiopathy, especially thrombotic thrombocytopenic purpura (TTP). Haemolytic‐uraemic syndrome (HUS) is less frequent in SLE. We report a case of such an association during an episode of severe lupus nephritis in a young woman, who was successfully treated with steroids, cyclophosphamide and especially plasma exchange with plasma replacement. This report highlights the importance of recognising atypical HUS in SLE patients by looking for schistocytes in case of haemolytic anemia with a negative antiglobulin test, in order to begin plasma exchange. |
| doi_str_mv | 10.1111/j.1445-5994.2011.02591.x |
| format | Article |
| fullrecord | <record><control><sourceid>wiley_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_inserm_00799554v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IMJ2591</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4111-e864f6e79c9dc19610c0d8922e007bc1c9156d8b1f48c871eb619fe67f2c524c3</originalsourceid><addsrcrecordid>eNqNkMtu1DAYha0KRC_wCsgPQILt2E6M1EWpYKZogE1v6sbyOL87HnKTPSmTt2_S0FnjjY_k8x3JH0KYkpSO5_M2pZyLRCjFU0YoTQkTiqb7I3RyeHjzknlCFMmO0WmMW0Jonin-Dh0zxnIpJDlBt0sDdVsNO2-TPozZWxyHpgxtDbjsg28ecYQnCICrvusjbqDbBL_z8QsG57w1dsCtw11lYm0w7O3GNI_wHr11porw4d99hm6-f7u-XCar34ury4tVYvn4jwQKyZ2EXFlVWqokJZaUhWIMCMnXllpFhSyLNXW8sEVOYS2pciBzx6xg3GZn6NO8uzGV7oKvTRh0a7xeXqy0byKEWo9TSgnBn-hYL-a6DW2MAdyBoURPZvVWTwL1JFBPZvWLWb0f0Y8z2vXrGsoD-KpyLJzPhb--guG_h_XVzx9TGvlk5n3cwf7Am_BHyzzLhb77tdCLa_FAxT3TX7NnDpCWvw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Haemolytic-uraemic syndrome during severe lupus nephritis: efficacy of plasma exchange</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Samson, M. ; Audia, S. ; Leguy, V. ; Berthier, S. ; Janikashvili, N. ; Martin, L. ; Bonnotte, B. ; Lorcerie, B.</creator><creatorcontrib>Samson, M. ; Audia, S. ; Leguy, V. ; Berthier, S. ; Janikashvili, N. ; Martin, L. ; Bonnotte, B. ; Lorcerie, B.</creatorcontrib><description>Systemic lupus erythematosus (SLE) has been described as a cause of thrombotic microangiopathy, especially thrombotic thrombocytopenic purpura (TTP). Haemolytic‐uraemic syndrome (HUS) is less frequent in SLE. We report a case of such an association during an episode of severe lupus nephritis in a young woman, who was successfully treated with steroids, cyclophosphamide and especially plasma exchange with plasma replacement. This report highlights the importance of recognising atypical HUS in SLE patients by looking for schistocytes in case of haemolytic anemia with a negative antiglobulin test, in order to begin plasma exchange.</description><identifier>ISSN: 1444-0903</identifier><identifier>EISSN: 1445-5994</identifier><identifier>DOI: 10.1111/j.1445-5994.2011.02591.x</identifier><identifier>PMID: 22276560</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Acute Kidney Injury ; Acute Kidney Injury - etiology ; Adult ; Biopsy ; Combined Modality Therapy ; Cyclophosphamide ; Cyclophosphamide - therapeutic use ; Drug Therapy, Combination ; Erythrocytes, Abnormal ; Female ; haemolyticuraemic syndrome ; Hemolytic-Uremic Syndrome ; Hemolytic-Uremic Syndrome - blood ; Hemolytic-Uremic Syndrome - diagnosis ; Hemolytic-Uremic Syndrome - drug therapy ; Hemolytic-Uremic Syndrome - etiology ; Hemolytic-Uremic Syndrome - therapy ; Humans ; Hydroxychloroquine ; Hydroxychloroquine - therapeutic use ; Immunology ; Immunosuppressive Agents ; Immunosuppressive Agents - therapeutic use ; Kidney ; Kidney - pathology ; Life Sciences ; Lupus Nephritis ; Lupus Nephritis - complications ; Lupus Nephritis - drug therapy ; Methylprednisolone ; Methylprednisolone - therapeutic use ; Models, Immunological ; Mycophenolic Acid ; Mycophenolic Acid - analogs & derivatives ; Mycophenolic Acid - therapeutic use ; Plasma Exchange ; Prednisone ; Prednisone - therapeutic use ; systemic lupus erythematosus ; thrombotic microangiopathy</subject><ispartof>Internal medicine journal, 2012-01, Vol.42 (1), p.95-98</ispartof><rights>2012 The Authors. Internal Medicine Journal © 2012 Royal Australasian College of Physicians</rights><rights>2012 The Authors. Internal Medicine Journal © 2012 Royal Australasian College of Physicians.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4111-e864f6e79c9dc19610c0d8922e007bc1c9156d8b1f48c871eb619fe67f2c524c3</citedby><cites>FETCH-LOGICAL-c4111-e864f6e79c9dc19610c0d8922e007bc1c9156d8b1f48c871eb619fe67f2c524c3</cites><orcidid>0000-0001-7229-3808 ; 0000-0003-1772-1392 ; 0000-0002-1098-4598</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1445-5994.2011.02591.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1445-5994.2011.02591.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22276560$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inserm.hal.science/inserm-00799554$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Samson, M.</creatorcontrib><creatorcontrib>Audia, S.</creatorcontrib><creatorcontrib>Leguy, V.</creatorcontrib><creatorcontrib>Berthier, S.</creatorcontrib><creatorcontrib>Janikashvili, N.</creatorcontrib><creatorcontrib>Martin, L.</creatorcontrib><creatorcontrib>Bonnotte, B.</creatorcontrib><creatorcontrib>Lorcerie, B.</creatorcontrib><title>Haemolytic-uraemic syndrome during severe lupus nephritis: efficacy of plasma exchange</title><title>Internal medicine journal</title><addtitle>Intern Med J</addtitle><description>Systemic lupus erythematosus (SLE) has been described as a cause of thrombotic microangiopathy, especially thrombotic thrombocytopenic purpura (TTP). Haemolytic‐uraemic syndrome (HUS) is less frequent in SLE. We report a case of such an association during an episode of severe lupus nephritis in a young woman, who was successfully treated with steroids, cyclophosphamide and especially plasma exchange with plasma replacement. This report highlights the importance of recognising atypical HUS in SLE patients by looking for schistocytes in case of haemolytic anemia with a negative antiglobulin test, in order to begin plasma exchange.</description><subject>Acute Kidney Injury</subject><subject>Acute Kidney Injury - etiology</subject><subject>Adult</subject><subject>Biopsy</subject><subject>Combined Modality Therapy</subject><subject>Cyclophosphamide</subject><subject>Cyclophosphamide - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Erythrocytes, Abnormal</subject><subject>Female</subject><subject>haemolyticuraemic syndrome</subject><subject>Hemolytic-Uremic Syndrome</subject><subject>Hemolytic-Uremic Syndrome - blood</subject><subject>Hemolytic-Uremic Syndrome - diagnosis</subject><subject>Hemolytic-Uremic Syndrome - drug therapy</subject><subject>Hemolytic-Uremic Syndrome - etiology</subject><subject>Hemolytic-Uremic Syndrome - therapy</subject><subject>Humans</subject><subject>Hydroxychloroquine</subject><subject>Hydroxychloroquine - therapeutic use</subject><subject>Immunology</subject><subject>Immunosuppressive Agents</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Kidney</subject><subject>Kidney - pathology</subject><subject>Life Sciences</subject><subject>Lupus Nephritis</subject><subject>Lupus Nephritis - complications</subject><subject>Lupus Nephritis - drug therapy</subject><subject>Methylprednisolone</subject><subject>Methylprednisolone - therapeutic use</subject><subject>Models, Immunological</subject><subject>Mycophenolic Acid</subject><subject>Mycophenolic Acid - analogs & derivatives</subject><subject>Mycophenolic Acid - therapeutic use</subject><subject>Plasma Exchange</subject><subject>Prednisone</subject><subject>Prednisone - therapeutic use</subject><subject>systemic lupus erythematosus</subject><subject>thrombotic microangiopathy</subject><issn>1444-0903</issn><issn>1445-5994</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMtu1DAYha0KRC_wCsgPQILt2E6M1EWpYKZogE1v6sbyOL87HnKTPSmTt2_S0FnjjY_k8x3JH0KYkpSO5_M2pZyLRCjFU0YoTQkTiqb7I3RyeHjzknlCFMmO0WmMW0Jonin-Dh0zxnIpJDlBt0sDdVsNO2-TPozZWxyHpgxtDbjsg28ecYQnCICrvusjbqDbBL_z8QsG57w1dsCtw11lYm0w7O3GNI_wHr11porw4d99hm6-f7u-XCar34ury4tVYvn4jwQKyZ2EXFlVWqokJZaUhWIMCMnXllpFhSyLNXW8sEVOYS2pciBzx6xg3GZn6NO8uzGV7oKvTRh0a7xeXqy0byKEWo9TSgnBn-hYL-a6DW2MAdyBoURPZvVWTwL1JFBPZvWLWb0f0Y8z2vXrGsoD-KpyLJzPhb--guG_h_XVzx9TGvlk5n3cwf7Am_BHyzzLhb77tdCLa_FAxT3TX7NnDpCWvw</recordid><startdate>201201</startdate><enddate>201201</enddate><creator>Samson, M.</creator><creator>Audia, S.</creator><creator>Leguy, V.</creator><creator>Berthier, S.</creator><creator>Janikashvili, N.</creator><creator>Martin, L.</creator><creator>Bonnotte, B.</creator><creator>Lorcerie, B.</creator><general>Blackwell Publishing Asia</general><general>Wiley</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-7229-3808</orcidid><orcidid>https://orcid.org/0000-0003-1772-1392</orcidid><orcidid>https://orcid.org/0000-0002-1098-4598</orcidid></search><sort><creationdate>201201</creationdate><title>Haemolytic-uraemic syndrome during severe lupus nephritis: efficacy of plasma exchange</title><author>Samson, M. ; Audia, S. ; Leguy, V. ; Berthier, S. ; Janikashvili, N. ; Martin, L. ; Bonnotte, B. ; Lorcerie, B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4111-e864f6e79c9dc19610c0d8922e007bc1c9156d8b1f48c871eb619fe67f2c524c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Acute Kidney Injury</topic><topic>Acute Kidney Injury - etiology</topic><topic>Adult</topic><topic>Biopsy</topic><topic>Combined Modality Therapy</topic><topic>Cyclophosphamide</topic><topic>Cyclophosphamide - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Erythrocytes, Abnormal</topic><topic>Female</topic><topic>haemolyticuraemic syndrome</topic><topic>Hemolytic-Uremic Syndrome</topic><topic>Hemolytic-Uremic Syndrome - blood</topic><topic>Hemolytic-Uremic Syndrome - diagnosis</topic><topic>Hemolytic-Uremic Syndrome - drug therapy</topic><topic>Hemolytic-Uremic Syndrome - etiology</topic><topic>Hemolytic-Uremic Syndrome - therapy</topic><topic>Humans</topic><topic>Hydroxychloroquine</topic><topic>Hydroxychloroquine - therapeutic use</topic><topic>Immunology</topic><topic>Immunosuppressive Agents</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Kidney</topic><topic>Kidney - pathology</topic><topic>Life Sciences</topic><topic>Lupus Nephritis</topic><topic>Lupus Nephritis - complications</topic><topic>Lupus Nephritis - drug therapy</topic><topic>Methylprednisolone</topic><topic>Methylprednisolone - therapeutic use</topic><topic>Models, Immunological</topic><topic>Mycophenolic Acid</topic><topic>Mycophenolic Acid - analogs & derivatives</topic><topic>Mycophenolic Acid - therapeutic use</topic><topic>Plasma Exchange</topic><topic>Prednisone</topic><topic>Prednisone - therapeutic use</topic><topic>systemic lupus erythematosus</topic><topic>thrombotic microangiopathy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Samson, M.</creatorcontrib><creatorcontrib>Audia, S.</creatorcontrib><creatorcontrib>Leguy, V.</creatorcontrib><creatorcontrib>Berthier, S.</creatorcontrib><creatorcontrib>Janikashvili, N.</creatorcontrib><creatorcontrib>Martin, L.</creatorcontrib><creatorcontrib>Bonnotte, B.</creatorcontrib><creatorcontrib>Lorcerie, B.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Internal medicine journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Samson, M.</au><au>Audia, S.</au><au>Leguy, V.</au><au>Berthier, S.</au><au>Janikashvili, N.</au><au>Martin, L.</au><au>Bonnotte, B.</au><au>Lorcerie, B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Haemolytic-uraemic syndrome during severe lupus nephritis: efficacy of plasma exchange</atitle><jtitle>Internal medicine journal</jtitle><addtitle>Intern Med J</addtitle><date>2012-01</date><risdate>2012</risdate><volume>42</volume><issue>1</issue><spage>95</spage><epage>98</epage><pages>95-98</pages><issn>1444-0903</issn><eissn>1445-5994</eissn><abstract>Systemic lupus erythematosus (SLE) has been described as a cause of thrombotic microangiopathy, especially thrombotic thrombocytopenic purpura (TTP). Haemolytic‐uraemic syndrome (HUS) is less frequent in SLE. We report a case of such an association during an episode of severe lupus nephritis in a young woman, who was successfully treated with steroids, cyclophosphamide and especially plasma exchange with plasma replacement. This report highlights the importance of recognising atypical HUS in SLE patients by looking for schistocytes in case of haemolytic anemia with a negative antiglobulin test, in order to begin plasma exchange.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>22276560</pmid><doi>10.1111/j.1445-5994.2011.02591.x</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-7229-3808</orcidid><orcidid>https://orcid.org/0000-0003-1772-1392</orcidid><orcidid>https://orcid.org/0000-0002-1098-4598</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1444-0903 |
| ispartof | Internal medicine journal, 2012-01, Vol.42 (1), p.95-98 |
| issn | 1444-0903 1445-5994 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_inserm_00799554v1 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | Acute Kidney Injury Acute Kidney Injury - etiology Adult Biopsy Combined Modality Therapy Cyclophosphamide Cyclophosphamide - therapeutic use Drug Therapy, Combination Erythrocytes, Abnormal Female haemolyticuraemic syndrome Hemolytic-Uremic Syndrome Hemolytic-Uremic Syndrome - blood Hemolytic-Uremic Syndrome - diagnosis Hemolytic-Uremic Syndrome - drug therapy Hemolytic-Uremic Syndrome - etiology Hemolytic-Uremic Syndrome - therapy Humans Hydroxychloroquine Hydroxychloroquine - therapeutic use Immunology Immunosuppressive Agents Immunosuppressive Agents - therapeutic use Kidney Kidney - pathology Life Sciences Lupus Nephritis Lupus Nephritis - complications Lupus Nephritis - drug therapy Methylprednisolone Methylprednisolone - therapeutic use Models, Immunological Mycophenolic Acid Mycophenolic Acid - analogs & derivatives Mycophenolic Acid - therapeutic use Plasma Exchange Prednisone Prednisone - therapeutic use systemic lupus erythematosus thrombotic microangiopathy |
| title | Haemolytic-uraemic syndrome during severe lupus nephritis: efficacy of plasma exchange |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T14%3A54%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Haemolytic-uraemic%20syndrome%20during%20severe%20lupus%20nephritis:%20efficacy%20of%20plasma%20exchange&rft.jtitle=Internal%20medicine%20journal&rft.au=Samson,%20M.&rft.date=2012-01&rft.volume=42&rft.issue=1&rft.spage=95&rft.epage=98&rft.pages=95-98&rft.issn=1444-0903&rft.eissn=1445-5994&rft_id=info:doi/10.1111/j.1445-5994.2011.02591.x&rft_dat=%3Cwiley_hal_p%3EIMJ2591%3C/wiley_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/22276560&rfr_iscdi=true |